UPC_CoA_121/2026
- Academy of Military Medical Sciences
- Gilead Sciences, Inc.
- Leave to appeal is granted;
Track this case
Get an email when a new order or decision is published in UPC_CoA_121/2026.
Decisions and documents (2)
- 2026-09-18procedural
- Applicant:
- Academy of Military Medical Sciences
- Respondent:
- Gilead Sciences, Inc.
dismissed
(i) Under Art. 74(2) UPCA, an appeal against a decision on actions or counterclaims for revocation has automatic suspensive effect, without the need for a decision by the Court of Appeal. It reflects the specific nature and effects of validity decisions, which apply erga omnes and are not confined to the legal relationship between the parties to the proceedings, and preserves the legal status of the patent while the decision on its validity remains subject to an appeal proceeding. By contrast, under Art. 74(1) UPCA, suspensive effect may be granted by the Court of Appeal, upon a motivated request, where the circumstances of the case justify a departure from the general rule. (ii) As an exception to a general rule, Art. 74(2) UPCA shall be given an application limited to its purpose and may not extend beyond its scope, from which it follows that, in case of an appeal against a decision on actions or counterclaims for revocation, the suspensive effect shall be limited to said decision. (iii) A decision on actions or counterclaims for revocation pursuant to Art. 74(2) UPCA refers to the substantive ruling by the Court on the issue of validity and its decision to revoke, or not, a patent. Although such a decision of the CFI may be part of a broader decision deciding other matters in the same case, the automatic suspensive effect of an appeal pursuant to Art. 74(2) UPCA remains limited to the part of the decision deciding on the validity of the patent and, if so ordered, its revocation. (iv) A decision on costs pursuant to Art. 69 UPCA and R. 150 ff RoP may not benefit from the automatic suspensive effect provided for under Art. 74(2) UPCA, even where the cost decision relates to proceedings in a claim for revocation of a patent. (v) When exercising its discretionary power to stay proceedings pursuant to R. 295 RoP, the Court shall consider the balance of interests of the parties and the specific circumstances of the case. When doing so in the context of a (counter)claim for revocation, the Court may, subject to the circumstances of the case, take into account the suspensive effect in the revocation proceedings.
• Panel: Emmanuel Gougé - 2026-08-04procedural
- Applicant:
- Academy of Military Medical Sciences
- Respondent:
- Gilead Sciences, Inc.
Appeal. Document: Order_R 221 and 223 Application_CoA_121-2026_AMMS v Gilead_2026_08_04_Signed.pdf. Case page: https://www.unifiedpatentcourt.org/en/node/183949
Weekly digest
A weekly email summarising new published decisions across European patent courts.